<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04735939</url>
  </required_header>
  <id_info>
    <org_study_id>xhechun5</org_study_id>
    <nct_id>NCT04735939</nct_id>
  </id_info>
  <brief_title>Chronotherapy for Radiotherapy of Glioma</brief_title>
  <official_title>Chronotherapy for Radiotherapy of Glioma</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>General Hospital of Ningxia Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>General Hospital of Ningxia Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to determine if there is any difference in the efficacy of radiotherapy for&#xD;
      glioma outcomes in the morning or in the evening. The study team believes that there may be a&#xD;
      benefit to taking the radiotherapy at a certain time of day. To test this theory the study&#xD;
      asks participants who are already taking radiotherapy for glioma consistently at either the&#xD;
      morning or in the evening based on when they currently take their radiotherapy. There will be&#xD;
      this study visits where the participant will be asked to fill in questionnaires related to&#xD;
      their neurological symptoms, their sleep habits, sleep quality, survival situation, and&#xD;
      general health information followed by a blood draw.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this study is to determine whether the timing of radiotherapy to treat&#xD;
      glioma has an effect on patient outcomes.&#xD;
&#xD;
      Primary objective: Determine whether there is a difference in outcomes seen when patients are&#xD;
      assigned to take their radiotherapy at either a morning time or evening time.&#xD;
&#xD;
      The Investigator hypothesize that administration time of radiotherapy during the day can&#xD;
      affect the clinical outcomes in glioma patients.&#xD;
&#xD;
      Specific Aims Include:&#xD;
&#xD;
        -  Determine whether morning vs. evening dosing radiotherapy could affect the survival time&#xD;
           of glioma patients.&#xD;
&#xD;
        -  Determine whether morning vs. evening dosing radiotherapy could affect the KPS score of&#xD;
           glioma patients.&#xD;
&#xD;
        -  Determine whether morning vs. evening dosing radiotherapy could affect the cognitive&#xD;
           function of glioma patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">February 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>survival time of glioma patients</measure>
    <time_frame>1/1/2021-31/12/2021</time_frame>
    <description>Determine whether morning vs. evening dosing radiotherapy could affect the survival time of glioma patients.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>KPS score of glioma patients.</measure>
    <time_frame>1/1/2021-31/12/2021</time_frame>
    <description>Determine whether morning vs. evening dosing radiotherapy could affect the KPS score of glioma patients.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>cognitive function of glioma patients</measure>
    <time_frame>1/1/2021-31/12/2021</time_frame>
    <description>Determine whether morning vs. evening dosing radiotherapy could affect the cognitive function of glioma patients.</description>
  </other_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>To Determine Whether the Timing of Radiotherapy Has an Effect on Patient Outcomes</condition>
  <arm_group>
    <arm_group_label>morning dosing radiotherapy</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>evening dosing radiotherapy</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>radiotherapy</intervention_name>
    <description>Determine whether there is a difference in outcomes seen when patients are assigned to take their radiotherapy at either a morning time or evening time.</description>
    <arm_group_label>evening dosing radiotherapy</arm_group_label>
    <arm_group_label>morning dosing radiotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The patients will be divided into two groups.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Age â‰¥ 18 years;&#xD;
&#xD;
          2. Pathological or cytological diagnosis of glioma;&#xD;
&#xD;
          3. Normal liver and kidney function.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Pregnant or lactating women;&#xD;
&#xD;
          2. Second primary malignancy;&#xD;
&#xD;
          3. Severe lung infection;&#xD;
&#xD;
          4. with high blood pressure although treated with medication;&#xD;
&#xD;
          5. Patients with myocardial ischemia or myocardial infarction, arrhythmia (including QT&#xD;
             interval &gt; 440 ms) or grade II cardiac insufficiency;&#xD;
&#xD;
          6. Arteriovenous thrombosis in 6 months prior to first administration, Such as&#xD;
             cerebrovascular accident (including temporary ischemic attack), deep vein thrombosis&#xD;
             and pulmonary embolism;&#xD;
&#xD;
          7. Serious heart, lung and bone marrow impairment;&#xD;
&#xD;
          8. History of severe hypertension or cerebral hemorrhage&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hechun Xia, bachelor</last_name>
    <phone>86-951-6743983</phone>
    <email>xhechun@aliyun.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>General Hospital of Ningxia Medical University</name>
      <address>
        <city>Yinchuan</city>
        <state>Ningxia</state>
        <zip>750004</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jie Wei, M.D.</last_name>
      <phone>86-951-6744528</phone>
      <email>nyfykyc@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 29, 2021</study_first_submitted>
  <study_first_submitted_qc>January 29, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 3, 2021</study_first_posted>
  <last_update_submitted>January 29, 2021</last_update_submitted>
  <last_update_submitted_qc>January 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>radiotherapy, glioma, outcomes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Glioma</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

